tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Cipher Pharmaceuticals’ Record Earnings Driven by Natroba
Company AnnouncementsCipher Pharmaceuticals’ Record Earnings Driven by Natroba
5d ago
Cipher Pharmaceuticals price target raised to C$20 from C$17 at Stifel
PremiumThe Fly
Cipher Pharmaceuticals price target raised to C$20 from C$17 at Stifel
6d ago
Cipher Pharmaceuticals price target raised to C$14 from C$13 at Canaccord
PremiumThe Fly
Cipher Pharmaceuticals price target raised to C$14 from C$13 at Canaccord
7d ago
Cipher Pharmaceuticals Reports Record Q2 2025 Revenue
PremiumCompany Announcements
Cipher Pharmaceuticals Reports Record Q2 2025 Revenue
9d ago
Cipher Pharmaceuticals Achieves Record Revenue in Q2 2025
PremiumCompany Announcements
Cipher Pharmaceuticals Achieves Record Revenue in Q2 2025
10d ago
Cipher Pharmaceuticals to Announce Q2 2025 Financial Results
PremiumCompany AnnouncementsCipher Pharmaceuticals to Announce Q2 2025 Financial Results
20d ago
Cipher Pharmaceuticals’ Shareholders Approve Key Resolutions at Annual Meeting
Premium
Company Announcements
Cipher Pharmaceuticals’ Shareholders Approve Key Resolutions at Annual Meeting
2M ago
Cipher Pharmaceuticals price target raised to C$13 from C$12.50 at Canaccord
Premium
The Fly
Cipher Pharmaceuticals price target raised to C$13 from C$12.50 at Canaccord
3M ago
Cipher Pharmaceuticals Reports Strong Revenue Growth in Q1 2025
PremiumCompany Announcements
Cipher Pharmaceuticals Reports Strong Revenue Growth in Q1 2025
3M ago
Cipher Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Cipher Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
3M ago
Cipher Pharmaceuticals Reports Strong Q1 2025 Results and Strategic Debt Repayment
PremiumCompany Announcements
Cipher Pharmaceuticals Reports Strong Q1 2025 Results and Strategic Debt Repayment
3M ago
CPHRF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CPHRF Upcoming Earnings Report: What to Expect?
3M ago
Cipher Pharmaceuticals to Announce Q1 2025 Financial Results
PremiumCompany AnnouncementsCipher Pharmaceuticals to Announce Q1 2025 Financial Results
4M ago
Cipher Pharmaceuticals’ Natroba™ Gains Preferred Status in Illinois Medicaid
Premium
Company Announcements
Cipher Pharmaceuticals’ Natroba™ Gains Preferred Status in Illinois Medicaid
4M ago
Cipher Pharmaceuticals Reports Robust Q4 2024 Growth
Premium
Company Announcements
Cipher Pharmaceuticals Reports Robust Q4 2024 Growth
5M ago
Cipher Pharmaceuticals Reports Strong 2024 Financial Growth
PremiumCompany Announcements
Cipher Pharmaceuticals Reports Strong 2024 Financial Growth
5M ago
Cipher Pharmaceuticals Achieves Robust Growth in 2024 with Strategic Acquisition
PremiumCompany Announcements
Cipher Pharmaceuticals Achieves Robust Growth in 2024 with Strategic Acquisition
5M ago
CPHRF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CPHRF Upcoming Earnings Report: What to Expect?
5M ago
Cipher Pharmaceuticals to Announce Q4 & Fiscal 2024 Results
PremiumCompany Announcements
Cipher Pharmaceuticals to Announce Q4 & Fiscal 2024 Results
5M ago
Cipher Pharmaceuticals Faces Setback but Eyes Growth
PremiumCompany AnnouncementsCipher Pharmaceuticals Faces Setback but Eyes Growth
8M ago
Cipher Pharmaceuticals price target lowered to C$17 from C$19 at Stifel
Premium
The Fly
Cipher Pharmaceuticals price target lowered to C$17 from C$19 at Stifel
9M ago
Cipher Pharmaceuticals Q3 2024 Results: Growth and Acquisitions
Premium
Company Announcements
Cipher Pharmaceuticals Q3 2024 Results: Growth and Acquisitions
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >